Kazuaki Tanabe

Last Updated :2024/07/04

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Health Sciences), Professor
E-mail
ktanabe2hiroshima-u.ac.jp
Other Contact Details
1-2-3, Kasumi, Minami-ku, Hiroshima, Japan, Japan
TEL : (+81)82-257-5380 FAX : (+81)82-257-5384
Self-introduction
Clinical and basic research for upper gastroenterological surgery Perioperative and Critical Care Management

Basic Information

Major Professional Backgrounds

  • 1994/05/16, 1994/11/30, Hiroshima University, Medical Hospital, Clinical Resident
  • 1994/12/01, 1997/03/31, Hiroshima City Asa Hospital
  • 1997/04/01, 1999/03/31, Hiroshima City Hospital
  • 1999/04/01, 2000/03/31
  • 2000/04/01, 2001/03/31
  • 2001/04/01, 2003/03/31
  • 2003/04/01, 2003/09/30, Hiroshima University, Medical Hospital, Clinical Fellow
  • 2003/10/01, 2004/03/30, Hiroshima University, Hospital, Clinical Fellow
  • 2004/04/01, 2004/07/31, Hiroshima University Hospital, Clinical Fellow
  • 2004/08/01, 2007/03/31, Hiroshima University, Research Institute for Radiation Biology and Medicine, Research Associate
  • 2007/04/01, 2008/08/31, Hiroshima University, Research Institute for Radiation Biology and Medicine, Assistant Professor
  • 2008/09/01, 2009/03/31, Hiroshima University Hospital, Lecturer
  • 2009/04/01, 2012/03/31, Hiroshima University, Graduate School of Biomedical Sciences, Lecturer
  • 2012/04/01, 2015/09/30, Hiroshima University, Institute of Biomedical & Health Sciences, Lecturer
  • 2015/10/01, 2019/03/31, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Associate Professor

Educational Backgrounds

  • Hiroshima University, Graduate School, Division of Medicine, Japan, 2000/04, 2003/03
  • Hiroshima University, Faculty of Medicine, Japan, 1988/04, 1994/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Health Sciences : Nursing
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Digestive surgery

Research Keywords

  • Wnt signaling
  • Cancer stem cell
  • Cancer

Affiliated Academic Societies

  • Japan Gastric Cancer Association

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  2. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  3. 2024, Undergraduate Education, Intensive, Integrated Clinical Practice
  4. 2024, Undergraduate Education, 2Term, Clinical pharmacology
  5. 2024, Undergraduate Education, 2Term, Clinical pharmacology
  6. 2024, Undergraduate Education, 1Term, Microbiology Immunology
  7. 2024, Undergraduate Education, 4Term, Disease Management in Gerontological Nursing
  8. 2024, Undergraduate Education, Year, Graduate thesis
  9. 2024, Undergraduate Education, Intensive, Interprofessional education
  10. 2024, Undergraduate Education, Second Semester, Anatomy and Physiology II
  11. 2024, Undergraduate Education, Intensive, Clinical Practice in Acute and Critical Care Nursing
  12. 2024, Undergraduate Education, Intensive, Clinical Practice in Rehabilitation Nursing
  13. 2024, Undergraduate Education, 1Term, Lecture of Patho-physiology for Adult Diseases I
  14. 2024, Undergraduate Education, 2Term, Clinical pharmacology
  15. 2024, Undergraduate Education, 2Term, Introduction to Rehabilitation Science
  16. 2024, Undergraduate Education, 2Term, Introduction to Rehabilitation Science
  17. 2024, Undergraduate Education, Intensive, Emergency Medicine and Risk Management
  18. 2024, Undergraduate Education, Intensive, Emergency Medicine and Risk Management
  19. 2024, Liberal Arts Education Program1, 1Term, Introductory Seminar for First-Year Students
  20. 2024, Graduate Education (Master's Program) , 1Term, Medical Ethics A
  21. 2024, Graduate Education (Doctoral Program) , 3Term, Medical Ethics B
  22. 2024, Graduate Education (Doctoral Program) , Second Semester, Methodology of Education for Health Promotion
  23. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Development of Nursing Science
  24. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Development of Nursing Science
  25. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Perioperative and Critical Care Management
  26. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Perioperative and Critical Care Management
  27. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Perioperative and Critical Care Management
  28. 2024, Graduate Education (Master's Program) , Year, Methodology of Education for Perioperative and Critical Care Management
  29. 2024, Graduate Education (Master's Program) , Year, Educational Practice on Perioperative and Critical Care Management
  30. 2024, Graduate Education (Master's Program) , Year, Integrated Educational Practice on Perioperative and Critical Care Management
  31. 2024, Graduate Education (Master's Program) , First Semester, Lecture on Perioperative and Critical Care Management
  32. 2024, Graduate Education (Master's Program) , First Semester, Seminar on Perioperative and Critical Care Management
  33. 2024, Graduate Education (Master's Program) , Second Semester, Seminar on Perioperative and Critical Care Management
  34. 2024, Graduate Education (Master's Program) , Year, Research on Perioperative and Critical Care Management

Research Activities

Academic Papers

  1. Hand-assisted laparoscopic surgery for an esophageal hiatal hernia with incarcerated transverse colon presenting after laparoscopic gastrectomy: a case report, SURGICAL CASE REPORTS, 9(1), 20230320
  2. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study, GASTRIC CANCER, 26(2), 307-316, 202303
  3. Deep sedation predicts pressure injury in patients admitted to intensive care units, NURSING IN CRITICAL CARE, 27(6), 877-884, 202211
  4. Massive bleeding from gastric ulcer-induced splenic artery pseudoaneurysm successfully treated with transcatheter arterial embolization and surgery: a case report, SURGICAL CASE REPORTS, 8(1), 20221011
  5. Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People, Critical Care Explorations, 3(11), e0576, 2021
  6. Hepatic resection using intraoperative ultrasound and near-infrared imaging with indocyanine green fluorescence detects hepatic metastases from gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 91, 202202
  7. Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 94, 202204
  8. Assessing optimal Roux-en-Y reconstruction technique after total gastrectomy using the Postgastrectomy Syndrome Assessment Scale-45, WORLD JOURNAL OF CLINICAL ONCOLOGY, 13(5), 376-387, 20220524
  9. Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers, BRITISH JOURNAL OF CANCER, 125(1), 65-77, 20210706
  10. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients, MEDICINE, 100(26), 20210702
  11. Annexin A10 is involved in the induction of pancreatic duodenal homeobox-1 in gastric cancer tissue, cells and organoids, ONCOLOGY REPORTS, 43(2), 581-590, 2020
  12. Thoracoscopic double-flap reconstruction for esophagogastric junction cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 67, 102-105, 2020
  13. Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population, CANCERS, 12(2), 2020
  14. Uc.63+contributes to gastric cancer progression through regulation of NF-kB signaling, GASTRIC CANCER, 23(5), 863-873, 2020
  15. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study, BMC GASTROENTEROLOGY, 20(1), 20200805
  16. Taste Disorders Effect of education in patients with breast cancer receiving chemotherapy, CLINICAL JOURNAL OF ONCOLOGY NURSING, 24(3), 265-271, 202006
  17. SPC18 Expression Is an Independent Prognostic Indicator of Patients with Esophageal Squamous Cell Carcinoma, PATHOBIOLOGY, 87(4), 254-261, 202009
  18. Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for advanced gastric cancer, ANNALS OF GASTROENTEROLOGICAL SURGERY, 4(5), 540-548, 202005
  19. Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell, ONCOGENE, 39(50), 7265-7278, 202010
  20. Iatrogenic hepatic granuloma (suspected liver metastatic lesion on imaging) caused by liver retraction during laparoscopic gastrectomy: A case report, CLINICAL CASE REPORTS, 8(12), 2353-2357, 2020
  21. Liver abscess caused by fish bone perforation of stomach wall treated by laparoscopic surgery: a case report, SURGICAL CASE REPORTS, 5, 20190515
  22. Perioperative management of polycythemia vera with advanced gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 58, 224-227, 2019
  23. Adenocarcinoma of the duodenum arising from Brunner's gland resected by partial duodenectomy: a case report, SURGICAL CASE REPORTS, 5(1), 201912
  24. The gastric carcinosarcoma with severe venous invasion: a case report, SURGICAL CASE REPORTS, 4, 20180130
  25. The long-term survival of stage IV gastric cancer patients with conversion therapy, GASTRIC CANCER, 21(2), 315-323, 201803
  26. Clinicopathological and Prognostic Significance of Epithelial Gremlin1 Expression in Gastric Cancer, ANTICANCER RESEARCH, 38(3), 1419-1425, 201803
  27. The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C), JOURNAL OF CANCER, 9(10), 1725-1730, 2018
  28. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial, GASTRIC CANCER, 21(5), 811-818, 201809
  29. Revascularization for cavernous transformation radical lymphadenectomy in the treatment of gastric cancer: A case report., Int J Surg Case Rep, 50, 84-87, 2018
  30. Palliative surgery for advanced gastric cancer: Partial gastrectomy using the inverted laparoscopic and endoscopic cooperative surgery method., Int J Surg Case Rep, 50, 42-45, 2018
  31. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)., Eur J Cancer, 101, 220-228, 2018
  32. Laparoscopic proximal gastrectomy with hinged double flap method using knotless barbed absorbable sutures: A case series., Int J Surg Case Rep, 51, 165-169, 2018
  33. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial., Gastric Cancer, 21(5), 811-818, 2018
  34. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II), EUROPEAN JOURNAL OF CANCER, 101, 220-228, 201809
  35. Palliative surgery for advanced gastric cancer: Partial gastrectomy using the inverted laparoscopic and endoscopic cooperative surgery method, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 50, 42-45, 2018
  36. Revascularization for cavernous transformation radical lymphadenectomy in the treatment of gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 50, 84-87, 2018
  37. Stimulation of natural killer cells with rhCD137 ligand enhances tumor-targeting antibody efficacy in gastric cancer, PLOS ONE, 13(10), 20181015
  38. Laparoscopic proximal gastrectomy with hinged double flap method using knotless barbed absorbable sutures: A case series, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 51, 165-169, 2018
  39. Possible role of soluble fibrin monomer complex after gastroenterological surgery, WORLD JOURNAL OF GASTROENTEROLOGY, 23(12), 2209-2216, 20170528
  40. ★, Predictive factors for body weight loss and its impact on quality of life following gastrectomy, WORLD JOURNAL OF GASTROENTEROLOGY, 23(26), 4823-4830, 20170714
  41. ★, Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer, ANNALS OF ONCOLOGY, 28(8), 1876-1881, 201708
  42. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer, JOURNAL OF PATHOLOGY, 243(1), 100-110, 201709
  43. A rare case of spontaneous rupture of an aneurysm of the right gastric artery, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 40, 27-31, 2017
  44. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer., Ann Surg Oncol, 24(2), 594-602, 201702
  45. Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study, GASTRIC CANCER, 19(1), 302-311, 201601
  46. Specific Features of Dumping Syndrome after Various Types of Gastrectomy as Assessed by a Newly Developed Integrated Questionnaire, the PGSAS-45, DIGESTIVE SURGERY, 33(2), 94-103, 2016
  47. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  48. Enhanced recovery program is safe and improves postoperative insulin resistance in gastrectomy, WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 8(5), 382-388, 20160527
  49. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer, EUROPEAN JOURNAL OF CANCER, 62, 103-111, 201607
  50. Feasibility and Safety of Transhiatal Approach and D2 Total Gastrectomy after Neoadjuvant Chemotherapy for Adenocarcinoma of the Esophago-Gastric Junction: A Subset Analysis of the COMPASS Trial, DIGESTIVE SURGERY, 33(5), 424-430, 2016
  51. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, 20160909
  52. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer., Ann Surg Oncol, 201602
  53. Laparoscopic extra-abdominal suturing technique for the repair of Larrey's diaphragmatic hernia using the port closure needle (Endo Close(R)): A case report., Int J Surg Case Rep, 2016
  54. ★, Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)., Ann Oncol, 26, 1916-1922, 2015
  55. Initial experiences of robotic versus conventional laparoscopic surgery for colorectal cancer, focusing on short-term outcomes: a matched case-control study, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, 20150312
  56. Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05), ANNALS OF ONCOLOGY, 26(9), 1916-1922, 201509
  57. Laparoscopic Repair and Percutaneous Endoscopic Gastrostomy to Treat Giant Esophageal Hiatal Hernia with Gastric Obstruction: A Case Report., Hiroshima J Med Sci, 64(1-2), 27-30, 2015
  58. Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study., Gastric Cancer, 19(1), 302-311, 2015
  59. ★, Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial, ANNALS OF SURGICAL ONCOLOGY, 21(1), 213-219, 201401
  60. ★, Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START), JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140(2), 319-328, 201402
  61. Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer., J Clin Oncol, 32(Suppl 3), abstr 164, 20140101
  62. ★, Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion., Cancer Science, 105, 1411-1420, 20140901
  63. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 12, 20140227
  64. ★, Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73(5), 1047-1054, 201405
  65. ★, Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and Changes in Body Weight are Useful Tools for Evaluation of Reconstruction Methods Following Distal Gastrectomy, ANNALS OF SURGICAL ONCOLOGY, 21, 370-378, 201406
  66. Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study, ANNALS OF SURGICAL ONCOLOGY, 21, 385-389, 201406
  67. ★, The Usefulness of Preoperative 18FDG Positron-Emission Tomography and Computed Tomography for Predicting the Malignant Potential of Gastrointestinal Stromal Tumors, DIGESTIVE SURGERY, 31(2), 79-86, 2014
  68. ★, Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial, LANCET ONCOLOGY, 15(8), 886-893, 201407
  69. Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy, ANNALS OF SURGICAL ONCOLOGY, 21(9), 3015-3022, 201409
  70. ★, Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation, PLOS ONE, 9(10), 20141030
  71. A case of gastric cancer following living donor liver transplantation., Hiroshima J Med Sci, 63, 23-26, 2014
  72. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery, SURGERY, 153(3), 344-356, 201303
  73. Safety and Efficacy of Laparoscopy-Assisted Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Retrospective Report., Journal of Cancer Therapy, 4(1), 54-60, 20130401
  74. A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42(1), 74-77, 201201
  75. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, 20120220
  76. Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report, BMC GASTROENTEROLOGY, 12, 20120731
  77. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor., Case Rep Gastroenterol, 6(2), 502-9, 20120701
  78. The roles of surgical oncologists in the new era - minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer, Pathobiology, 78(6), 343-52, 20111101
  79. The roles of surgical oncologists in the new era - minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer, Pathobiology, 78(6), 343-52, 20111101
  80. Triple-Tube-Ostomy: A Novel Technique for the Surgical Treatment of Iatrogenic Duodenal Perforation, Case Reports in Gastroenterology, 5(3), 672-679, 20111201
  81. ★, A New Method for Intraluminal Gastrointestinal Stromal Tumor Resection Using Laparoscopic Seromuscular Dissection Technique, Digestive Surgery, 27(6), 461-465, 20101201
  82. Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis, World J Surg Oncol, 8, 40, 20100501
  83. Thoracoscopic-assisted repair of a Bochdalek hernia in an adult: a case report, J Med Case Reports, 4(1), 366, 20101101
  84. Preliminary trial of adjuvant surgery for advanced gastric cancer, Oncol Lett, 1, 743-747, 20100501
  85. Preliminary trial of adjuvant surgery for advanced gastric cancer, ONCOLOGY LETTERS, 1(4), 743-747, 2010
  86. Skin tube reconstruction for esophageal defect due to postoperative complication, Ann Thorac Surg, 87(5), 1605-7, 20090501
  87. S-1+docetaxel, 66(増刊5 胃癌), 409-413, 20081001
  88. Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines, Oncol Rep, 17(1), 161-7, 20070101
  89. Kidney metastasis of resected early gastric carcinoma: report of a case, Surg Today, 37(3), 248-50, 20070301
  90. Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy, CANCER GENE THERAPY, 14(1), 1-11, 200701
  91. Cancer immunoediting from immune surveillance to immune escape, IMMUNOLOGY, 121(1), 1-14, 200705
  92. Potential functional role of plasmacytoid dendritic cells in cancer immunity, IMMUNOLOGY, 121(2), 149-157, 200706
  93. Role of the unfolded protein response in cell death, APOPTOSIS, 11(1), 5-13, 200601
  94. Role of mitochondria as the gardens of cell death, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 57(5), 545-553, 200603
  95. Regulation and interplay of apoptotic and non-apoptotic cell death, JOURNAL OF PATHOLOGY, 208(3), 319-326, 200602
  96. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment, EJSO, 32(3), 269-277, 200604
  97. Potential role of HER-2 in primary breast tumor with bone metastasis, ONCOLOGY REPORTS, 15(6), 1477-1484, 200606
  98. Tumor-driven evolution of immunosuppressive networks during malignant progression, CANCER RESEARCH, 66(11), 5527-5536, 20050601
  99. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines, INTERNATIONAL JOURNAL OF CANCER, 119(4), 783-791, 20060815
  100. Extranuclear expression of hormone receptors in primary breast cancer, ANNALS OF ONCOLOGY, 17(8), 1213-1220, 200608
  101. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity, IMMUNOLOGY, 119(2), 254-264, 200610
  102. Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity, CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 146(2), 189-196, 200611
  103. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance, ONCOLOGY REPORTS, 16(6), 1165-1172, 200612
  104. Immunobiology of the sentinel lymph node and its potential role for antitumour immunity, LANCET ONCOLOGY, 7(12), 1006-1016, 200612
  105. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 26(4), 1025-1031, 200504
  106. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma, CANCER, 103(9), 1800-1809, 20050501
  107. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells, CANCER, 103(10), 2199-2207, 20050515
  108. Caspase-dependent and -independent cell death pathways after DNA damage (review), ONCOLOGY REPORTS, 14(3), 595-599, 200509
  109. Targeted therapy against Bcl-2-related proteins in breast cancer cells, BREAST CANCER RESEARCH, 7(6), R940-R952, 2005
  110. Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses, CANCER BIOLOGY & THERAPY, 4(9), 924-933, 200509
  111. Neoadjuvant chemotherapy for local advanced breast cancer with stageIIIB, Oncology Report, 11, 1265-72, 20040301
  112. The role of fas ligand and transforming growth factor beta in tumor progression - Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy, CANCER, 100(11), 2281-2291, 20040601
  113. Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma, CANCER, 101(10), 2177-2186, 20041115
  114. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy, CANCER, 101(11), 2491-2502, 20041201
  115. Antisense Bcl-2 and HER-2 oligonucleotide, treatment of breast cancer cells enhances their sensitivity to anticancer drugs, INTERNATIONAL JOURNAL OF ONCOLOGY, 22(4), 875-881, 200304
  116. Inducing cancer cell death by targeting transcription factors, ANTI-CANCER DRUGS, 14(1), 3-11, 200301
  117. Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations, ANTI-CANCER DRUGS, 14(9), 715-723, 200310
  118. Current status of the molecular mechanisms of anticancer drug-induced apoptosis - The contribution of molecular-level analysis to cancer chemotherapy, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 50(5), 343-352, 200211
  119. Branching form of celiac artery to be aware of in laparoscopic surgery: A case report using MDCT angiography., Radiol Case Rep, 16, 476-479, 202012
  120. PRESENT STATUS AND PROBLEMATIC POINTS OF DAY SURGERY OF BREAST CANCER, 60(9), 2283-2290, 19990925
  121. Kidney Metastasis of Resected Early Gastric Carcinoma : Report of a Case, 37(3), 248-250, 20070301
  122. A STUDY ON THE ADEQUATE EXTENT OF DISSECTION OF REGIONAL LYMPH NODES FOR t_2 AND t_3 GASTRIC CANCER, 60(12), 3088-3092, 19991225
  123. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance, GASTRIC CANCER, 24(6), 1264-1277, 202111
  124. Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials, GASTRIC CANCER, 24(6), 1184-1193, 202111
  125. Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy, CANCERS, 14(2), 202201

Invited Lecture, Oral Presentation, Poster Presentation

  1. Analysis of the Type and Characteristics of Traffic Accidents Requiring the Transport of Patients Using Emergency Medical Services, Ayako Notsu, Chie Teramoto, Kazuaki Tanabe, Hiroyuki Sawatari, 2024 EAFONS, 2024/03/06, Without Invitation, English
  2. Characteristics of Older People Who Called for Emergency Medical Services Because of Self-Harms, Akari Kimura , Chie Teramoto, Kazuaki Tanabe , Hiroyuki Sawatari, 2024 EAFONS, 2024/03/06, Without Invitation, English
  3. Features of Non-Transported Patients Compared to Transported Patients in EMS Call Fatality Cases ;Focusing on Continuous Support for Grief Care, Kurumi Shirakawa , Chie Teramoto , Kazuaki Tanabe , Hiroyuki Sawatari, 2024 EAFONS, 2024/03/06, Without Invitation, English
  4. Difficulty and Needs of Breast Cancer Patients Who Develop Chemotherapy -Induced Heart Failure, Atsuyoshi Norishige, Kazuaki Tanabe, Chie Teramoto,  Hiroyuki Sawatari, 2024 EAFONS, 2024/03/06, Without Invitation, English
  5. Associated Factors Between Readiness and Adjustment to Nursing Home Life of Older Adults in Japan A Cross-Sectional Study, Haruka Yoshimaru, Kazuaki Tanabe , Chie Teramoto, Hiroyuki Sawatari, EAFONS 2024, 26th East Asian Forum of Nursing Scholars, 2024/03/06, Without Invitation, English
  6. Evaluation of proximal gastrectomy with hinged double flap method for EGJ cancer, 2022/07/20, Without Invitation, Japanese
  7. Current status and outcome of Robotic gastrectomy for gastric cancer, K, Tanabe., Y, Saeki., Y, Yamamoto, H, Ohta., R, Saito and H, Ohdan, 2020/12/15, Without Invitation, English
  8. Our procedure and postoperative outcome of laparoscopic gastrectomy with hinged double flap method, Tanabe K, Saeki Y, Ohta H, Chikuie E, Ide R, Takemot Y and Ohdan H, 2021/03/03, Without Invitation, English
  9. Conversion surgery for patients with liver metastasis from gastric cancer, International gastric cancer congress, 2019/05/10, Without Invitation, English, PRAGUE
  10. Robotic proximal gastrectomy with hinged double flap method, 2019/02/27, Without Invitation, Japanese
  11. A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II), Kobayashi M, Tanabe K et al., ASCO-GI, 2015/01/15, Without Invitation, English
  12. A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally resectable advanced gastric cancer: Survival results of COMPASS., Yoshikawa T, Tanabe K et al., ASCO-GI, 2015, 2015/01/15, Without Invitation, English
  13. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS)., Takahashi M, Tanabe K et al., ASCO-GI, 2015, 2015/01/15, Without Invitation, English
  14. Predictive Biomarker analysis to Neoadjuvant Chemotherapy in Locally advanced Gastric Cancer, Kazuaki Tanabe, 2016/10/22, Without Invitation, Japanese, Yokohama
  15. Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: An exploratory study of the randomized phase II COMPASS trial., Kazuaki Tanabe, ESMO 2016, 2016/10/11, Without Invitation, English
  16. Aiming of surgical resection of hepatic metastasis from gastric cancer, 2018/03/08, Without Invitation, English
  17. Conversion surgery in patients with liver metastasis from gastric cancer, 2017/07/21, Without Invitation, English
  18. Aiming to establish the indication of conversion surgery for gastric cancer, K.Tanabe, R. Hotta, Y. Saeki, Y.Yamamoto, K.Ohta, H.Ohdan, 73th General meeting of the Japanese Society of Gastroentorological Surgery, 2018/07/13, Without Invitation, English
  19. Function analysis of Desmoglein1 in gastric cancer., Y.Yamamoto, N.Oue, Y.Imai, R.Asai, K.Tanabe, H.Ohdan, N,Sakamoto, K.Sentani K.Yoshida, W.Yasui, 77th Annual meeting of Japanese cancer association, 2018/09/27, Without Invitation, Japanese

Awards

  1. 2015/11/13, Phoenix Outstanding Researcher Award, Hiroshima University